Stay updated on Pembrolizumab for Genomic Instability Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.

Latest updates to the Pembrolizumab for Genomic Instability Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now reflects a newer revision label (v3.6.3) replacing the previous one (v3.6.2), indicating an updated version of the study documents.SummaryDifference0.1%

- Check18 days agoChange DetectedUpdated Study Documents section now lists the Informed Consent Form (2022-05-11) and Study Protocol/Statistical Analysis Plan (2023-02-22), and adds IPD sharing information and expanded metadata/MeSH terms.SummaryDifference59%

- Check32 days agoChange DetectedThe page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Study Plan header to Intervention/Treatment, while removing the older header spacing and bumping the revision version to v3.6.0. The recruitment status was changed to no longer recruiting, affecting enrollment availability.SummaryDifference0.4%

- Check39 days agoChange DetectedUpdated the document revision from v3.5.4 to v3.5.5 in the Study Plan documents. This indicates a newer version of the protocol and SAP is now referenced on the page.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page shows a revision update from v3.5.3 to v3.5.4, indicating a minor page update; no changes to the study data or eligibility criteria are indicated.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s displayed revision/version number has been bumped from v3.5.2 to v3.5.3, reflecting a website release update rather than a change to the study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Genomic Instability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.